Category: Glossary

Selective breeding is the deliberate choice of specific sires and dams based on heritable traits the breeder wants to increase, speed, conformation, temperament, coat color, disease resistance, with the effect of raising the frequency of favorable alleles across successive generations. It is the mechanism by which every established horse breed was created and the primary tool of modern breed improvement programs.

The effectiveness of selective breeding depends on three factors: the heritability of the target trait (how much of the variation in that trait is genetic rather than environmental), the selection differential (how far above or below average the selected parents are for that trait), and the generation interval (how often new offspring can be evaluated and selected). Traits with high heritability, bone density, body dimensions, some performance metrics, respond predictably to selection; traits with lower heritability require larger populations and more generations. The foal-to-breeding-age interval of roughly three years makes the horse a slower species to select in than, for example, cattle or pigs.

Long-term selective breeding can narrow the genetic base of a breed, increasing the risk of inbreeding depression, reduced fertility, immune function, and viability in the offspring crop. Breed registries manage this through outcrossing policies, careful pedigree analysis, and, in some breeds, controlled infusion of outside genetics. The relationship between a closed studbook and a performance-oriented open studbook reflects different trade-offs between trait concentration and genetic diversity.

Further Reading: Wikipedia’s article on selective breeding explains heritability, selection differentials, and the population-genetics basis of breed improvement across species. The Wikipedia entry on progeny testing covers how offspring records are used to infer breeding value more accurately than phenotyping the parent alone.

A sedative is a drug that reduces a horse’s anxiety, lowers its responsiveness to stimuli, and may produce drowsiness or light anesthesia depending on dose. Equine sedatives are used for procedures requiring the horse to stand quietly, veterinary examinations, minor wound treatment, routine dental work, farriery on a difficult horse, trailer loading in extreme cases, and for pre-surgical induction alongside general anesthetics.

The most commonly used equine sedatives are alpha-2 adrenergic agonists: xylazine (short-acting, 20-30 minutes), detomidine (intermediate, 60-90 minutes), and romifidine. These agents lower heart rate, cause head-drop and ataxia, and reduce the horse’s response to pain and handling. Acepromazine (a phenothiazine tranquilizer) reduces anxiety and excitability without full sedation; it is often combined with alpha-2 agonists but is contraindicated in horses that are in shock, severely dehydrated, or at breeding risk in stallions due to paraphimosis risk.

All equine sedatives require veterinary prescription and weight-based dosing. An underdosed horse may react unpredictably; an overdosed horse risks cardiovascular depression, collapse, or neurological crisis. Reversal agents (atipamezole, yohimbine) exist for alpha-2 agonists and should be on hand in clinical settings. Never administer a sedative without veterinary guidance, individual horses vary significantly in sensitivity, and the margin between sedation and overdose is narrower than in many other species.

Further Reading: Wikipedia’s article on xylazine covers pharmacology, dosing ranges, and species-specific effects for the most widely used equine sedative. The broader drug class is explained in the Wikipedia overview of alpha-2 adrenergic agonists, which includes detomidine and romifidine alongside xylazine.

Luster refers to the sheen and reflective quality visible on a horse’s coat when the individual hair shafts are smooth, clean, and well-nourished. A coat with good luster has a glossy, light-catching surface that is recognized as one of the most visible external indicators of a horse’s overall health and nutritional status. The optical property arises from the microscopic structure of the hair shaft: healthy hair has a smooth, tight cuticle layer that reflects incident light uniformly, while a dull, rough, or brittle coat indicates cuticle disruption caused by nutritional deficiency, parasite burden, systemic illness, hormonal disorder, or inadequate grooming.

Luster is influenced by multiple factors simultaneously. Dietary adequacy is foundational: deficiencies in protein (particularly amino acids such as lysine and methionine needed for keratin synthesis), essential fatty acids (especially omega-3s from flaxseed or fish oil), vitamin E, copper, and zinc each reduce coat quality in measurable ways. Grooming practice matters significantly, regular curry combing distributes sebum (natural skin oil) along the hair shaft, producing a natural gloss that supplements cannot replicate on their own. Breed contributes to baseline sheen: Thoroughbred-type horses and American Saddlebred horses are often noted for particularly fine, lustrous coats as a breed trait, while cold-blood breeds typically carry coarser, less reflective coats.

A sudden or progressive loss of luster is clinically significant. It may indicate internal parasitism (see parasite burden dulling the coat), Cushing’s disease (PPID), which disrupts the normal coat shedding cycle and produces a long, curly, non-shedding coat with markedly reduced sheen, endocrine disorders, chronic stress, or systemic inflammatory disease. A horse presented with dull coat alongside weight loss should be assessed with a formal parallel health assessment alongside coat quality evaluation and a full health history review before attributing the change to nutrition alone. Improving coat luster through supplementation alone, without addressing the underlying cause, produces inconsistent results.

Further Reading: The optical properties behind coat sheen are explained in the Wikipedia overview of equine coat and color genetics. For the underlying hair-shaft biology, see the Wikipedia entry on hair follicle structure and function.

Roughage is the high-fiber plant material, hay, pasture grass, straw, and similar forages, that forms the nutritional and digestive foundation of a horse’s diet. Horses are hindgut fermenters with a digestive system evolved for continuous consumption of fibrous plant material; the cecum and large colon depend on a steady supply of roughage to maintain microbial populations and normal gut motility. A minimum of 1 to 1.5 percent of body weight in roughage per day (roughly 10 to 15 pounds for a 1,000-pound horse) is the standard threshold below which colic risk increases measurably.

The primary roughage sources are grass hay (timothy, orchard grass, Bermuda), legume hay (alfalfa, clover), and managed pasture. Legume hays are higher in protein and calcium than grass hays; their caloric density makes them suitable for performance horses and lactating mares but potentially too rich for easy keepers. Straw provides fiber with very low nutritional value and is sometimes fed as a dry-matter supplement for horses on restricted rations.

Forage quality is assessed by dry matter, crude protein, digestible energy, calcium-to-phosphorus ratio, and non-structural carbohydrate content. Horses with metabolic conditions such as equine metabolic syndrome or laminitis require roughage with low non-structural carbohydrates; soaking hay reduces water-soluble carbohydrates when tested forage exceeds the threshold. In the context of a cost-effective feeding plan, roughage sourced locally or purchased in bulk represents the most economical nutritional base.

Further Reading: Wikipedia’s overview of forage as an animal feed category covers hay types, nutritional composition, and the role of fiber in herbivore digestion. The Wikipedia article on equine colic explains why insufficient roughage intake is a primary risk factor for digestive obstruction and displacement.

Splayed feet, also described as splay-footed or toe-out, is a conformation fault in which the front hooves turn outward from the vertical axis of the limb, with the heels pointing inward. The deviation can originate at the knee, the medial joint stress from outward rotation, or the hoof itself. When the rotation is present from the knee down, the entire lower column swings outward; when it originates at the hoof capsule only, the rotation is more limited and the structural impact is less severe.

The primary consequence of splayed feet is abnormal rotational stress on the lower limb joints, coffin joint, pastern, and fetlock, as the foot breaks over the inner toe rather than centrally. This predisposes the horse to medial (inside) joint wear, ringbone, and windpuffs. The outward swing of the foot during the flight phase of the stride also increases the risk of paddling (an outward arc) and interfering (striking the opposite leg), both of which are faults visible at the trot.

Mild splay can be partially managed by corrective corrective trimming for straighter breakover: trimming to encourage a straighter breakover, but structural deviation at the knee or higher cannot be corrected by shoeing. In young foals, some degree of toe-out is normal and often self-corrects as the limb strengthens; in a grown horse, the deviation is permanent. When evaluating a horse for purchase, note whether the deviation is symmetric (present in both front feet to the same degree) and whether the associated joints show signs of existing wear or swelling.

Further Reading: The biomechanics of limb deviation and toe-out stance are covered in the Wikipedia article on valgus deformity. For the full context of structural evaluation, see the Wikipedia overview of horse conformation.

Progeny is the collective term for the offspring of a horse. A sire or dam produces progeny over successive breeding seasons, and evaluating that progeny, their conformation, soundness, gaits, and competition results, is the primary method of assessing a horse’s genetic value as a breeding animal.

In breed registries and auction catalogs, progeny records list a stallion’s foal crops alongside the performance of notable individual offspring. A stallion producing many high-performing progeny commands higher breeding fees; a mare with a strong progeny record is valued as a broodmare. The term applies to immediate offspring only, the offspring of progeny are grandprogeny or, more commonly, simply described by generation (F1, F2) in breed improvement programs.

Progeny testing, measuring the traits of offspring to infer a parent’s breeding value, is more reliable than evaluating the parent animal alone, because phenotypic performance in a single horse may reflect environment or training rather than heritable genetics. Breed improvement through selection depends on accurate progeny records across a large enough sample from a given founding ancestor.

Further Reading: Wikipedia’s article on progeny testing explains how measuring offspring traits produces a more reliable estimate of a parent’s breeding value than evaluating the parent alone, the core methodology behind stallion and broodmare performance records. The Wikipedia entry on selective breeding provides the broader population-genetics framework in which progeny evaluation is applied.

Arthritis is chronic inflammation of a joint, resulting in the progressive degradation of articular cartilage and the underlying bone. In horses the condition most often affects high-load joints, the fetlock, the hock (where bone spavin forms), and the pastern articulations, where repetitive stress and concussive forces accelerate cartilage loss. Once cartilage thins, bone contacts bone, producing pain, heat, swelling, and reduced range of motion.

The most clinically significant form in the horse is degenerative joint disease (DJD), which develops gradually through normal wear in aging horses or more rapidly following injury, poor conformation, or sustained overwork. The pastern joint is the site of ringbone, and the distal hock joints produce the arthritic syndrome known as bone spavin, both are recognized forms of DJD. A horse with low-grade arthritis may show only intermittent stiffness or shortened stride at first; as the joint space narrows, lameness becomes consistent and identifiable at a specific joint on flexion testing.

Management centers on reducing inflammation and preserving joint function. NSAIDs such as phenylbutazone control pain. Intra-articular corticosteroid injections, hyaluronic acid, and newer biologics such as IRAP (interleukin-1 receptor antagonist protein) are used to slow cartilage breakdown and reduce synovial inflammation. Regular, appropriate exercise on good footing maintains joint fluid distribution and slows progression better than rest alone. A skilled farrier plays a direct role, corrective shoeing that reduces rotational forces on affected joints can extend a horse’s working life considerably. The condition is not cured; it is managed.

Further reading: Arthritis on Wikipedia; Arthritis at Britannica.

Hepatitis in horses is inflammation of the liver, which can arise from multiple causes: ingestion of hepatotoxic plants such as ragwort (Senecio spp.) or pyrrolizidine alkaloid-containing forage, infection by viruses or bacteria, mycotoxins in moldy feed, drug toxicity, or chronic copper accumulation. The liver has a large functional reserve, meaning a horse can lose a substantial portion of hepatic tissue before signs of liver failure become apparent , this latency makes early-stage hepatitis difficult to detect without blood testing.

Clinical signs of hepatic disease in horses range from subtle to severe. Early signs may include abdominal pain that mimics colic, weight loss, reduced appetite, and behavioral change. As liver function deteriorates, photosensitization (sunburn-like skin lesions in unpigmented areas), jaundice (icterus) visible in the sclera and mucous membranes, head pressing, circling, apparent blindness, and hepatic encephalopathy may develop. These neurological signs indicate advanced compromise. Serum liver enzyme elevations , notably gamma-glutamyltransferase (GGT), sorbitol dehydrogenase (SDH), and bilirubin , are the primary diagnostic indicators and should be part of the routine veterinary workup in horses with access to pasture containing unknown plants.

Prognosis depends on the cause, extent of liver damage, and whether the toxic source has been removed. Pyrrolizidine alkaloid toxicity causes progressive and irreversible fibrosis; affected horses may survive months before decompensation. Serum heme breakdown products tracked in prognosis degradation markers and liver biopsy can guide prognosis. Management focuses on removing the toxic source, providing a low-protein diet to reduce hepatic load, and supporting the horse through the underlying condition if treatable. Pasture safety , identifying and removing hepatotoxic plants , is the primary prevention strategy.

Further Reading

• Theiler's disease (equine serum hepatitis) on Wikipedia
• Hepatic Disease in Large Animals, Merck Veterinary Manual

Ataxia is a clinical sign, not a disease, defined as the loss of voluntary coordination of muscle movement. In horses it manifests as stumbling, swaying, crossing of limbs, dragging of toes, or difficulty maintaining balance, particularly on uneven ground or when turning. The severity is graded on a 0-to-5 scale: grade 0 is normal; grade 5 is recumbent and unable to rise.

The underlying cause is always a lesion somewhere in the nervous system’s proprioceptive or motor pathway, the spinal cord, cerebellum, vestibular apparatus, or brainstem. In horses, the most common cause of progressive spinal ataxia is cervical vertebral myelopathy (wobbler syndrome), in which malformed or unstable cervical vertebrae compress the spinal cord. Other causes include equine protozoal myeloencephalitis (EPM), equine herpesvirus myeloencephalopathy (EHV-1), trauma, and toxin ingestion. Each has a distinct distribution of deficits, hindlimb-only ataxia suggests a thoracolumbar lesion; four-limb ataxia with head tremor implicates the cerebellum.

Ataxia is a veterinary emergency when it appears suddenly or progresses rapidly. A horse that cannot coordinate its hindquarters is a danger to itself and to handlers. Diagnosis uses neurological examination, cervical radiographs, cerebrospinal fluid analysis, and Western blot testing for EPM. Management depends entirely on the underlying lesion, EPM is treated with antiprotozoal drugs; wobbler syndrome may require surgical stabilization in severe cases. The prognosis ranges from full recovery (mild EPM caught early) to euthanasia (severe cord compression). Equine anatomy: particularly the cervical skeletal structures: guides the clinician in localizing where in the nervous system the lesion is likely to sit.

Further Reading: The Wikipedia article on ataxia covers the neurological basis of the condition across species; the Merck Veterinary Manual’s section on disorders of the spinal column and cord in horses covers wobbler syndrome and other causes of progressive equine ataxia in clinical detail.

Anemia is a reduction in the number of circulating red blood cells, the concentration of hemoglobin, or both, below established normal reference ranges for horses. Because red blood cells carry oxygen bound to hemoglobin, anemia impairs the blood’s capacity to deliver oxygen to working muscles and organs.

Causes in horses fall into three categories: blood loss (acute hemorrhage from injury or surgery, or chronic loss from gastrointestinal parasitism), increased red cell destruction (hemolytic anemia, which can be caused by neonatal isoerythrolysis in foals, equine infectious anemia, or oxidative toxins), and decreased red cell production (iron deficiency, chronic inflammatory disease, or bone marrow suppression). Horses have a large splenic reserve of red cells that they release during exercise, which means early or mild anemia may not produce obvious signs at rest.

Clinical signs when anemia becomes significant include pale or white mucous membranes, reduced exercise tolerance, elevated resting heart and respiratory rates, and rapid fatigue. Diagnosis requires a complete blood count (CBC) to measure packed cell volume (PCV), red cell count, and hemoglobin. Normal equine PCV is approximately 32–48%; values below 28% typically produce visible clinical signs. Treatment depends entirely on cause: parasitism-driven chronic anemia responds to a targeted deworming program, while hemolytic or production-failure anemia may require transfusion or specific therapy. Any horse showing pale membranes warrants prompt veterinary evaluation.

Further Reading

• Anemia: Wikipedia overview of anemia types, causes, and diagnostic criteria across species.
• Overview of anemia in veterinary species: Merck Veterinary Manual clinical reference on classification, workup, and management.